Telix Pharmaceuticals reported AUD7.62M in Interest Expense on Debt for its fiscal semester ending in December of 2025.





Interest Expense On Debt Change Date
Cochlear AUD 6.3M 3.65M Dec/2025
CSL USD 215M 111M Dec/2025
Integral Diagnostics AUD 5.34M 6.08M Jun/2024
Mayne Pharma AUD 1.2M 50K Jun/2024
Medical Developments International AUD 18K 3K Jun/2025
Mesoblast USD 10.83M 368K Dec/2024
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Paradigm Biopharmaceuticals AUD 1000 3K Jun/2025
Polynovo AUD 506K 130K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Ramsay Health Care AUD 300.6M 15.5M Dec/2025
ResMed USD 775K 886K Dec/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024